93 stocks hit 52-Week highs; 51 touched 52-week lows today
By Ankur Chandra | Published at: Jul 29, 2025 06:14 PM IST
Mumbai, July 29, 2025: Indian equities experienced a mixed trading session on Tuesday, reflecting divergent investor sentiment amidst the ongoing earnings season and broader market volatility. While 93 stocks touched fresh 52-week highs, 51 stocks slipped to their respective yearly lows.
Top Stocks at Fresh 52-Week Highs (At The Market Close: 29 July)
Several midcap and SME names witnessed strong buying interest, propelling them to fresh highs:
| Company Name | Symbol | New 52-Week High (₹) | Previous 52-Week High (₹) | LTP (₹) | % Change |
|---|---|---|---|---|---|
| Bosch Ltd | BOSCHLTD | 40,080 | 39,088.80 | 39,915 | +4.39% |
| Osel Devices | OSELDEVICE | 420.2 | 368.00 | 420.2 | +19.99% |
| Hind Rectifiers | HIRECT | 1,712.2 | 1,588.15 | 1,712.2 | +19.99% |
| InfoBeans Tech | INFOBEAN | 623.2 | 598.00 | 623.2 | +9.99% |
| Punjab Chemicals | PUNJABCHEM | 1,548.00 | 1,398.85 | 1,547.00 | +14.36% |
| Flair Writing Ind. | FLAIR | 349.5 | 342.50 | 341.90 | +7.58% |
| Fedbank Financial | FEDFINA | 133.39 | 132.01 | 132.22 | +7.18% |
| Mangalore Chem & Fert. | MANGCHEFER | 365.4 | 333.90 | 354.25 | +9.54% |
| Vimta Labs | VIMTALABS | 721.5 | 680.00 | 710.30 | +7.80% |
Other notable names included Laurus Labs (₹909.85, +2.32%), Anthem Biosciences (₹782.45, +3.51%), and Torrent Pharma (₹3,768.10, +4.01%).
Stocks That Slipped to 52-Week Lows
On the downside, 51 stocks fell to fresh yearly lows, signalling pressure in select counters, particularly in microcaps and lesser-tracked SME stocks.
| Company Name | Symbol | New 52-Week Low (₹) | Previous 52-Week Low (₹) | LTP (₹) | % Change |
|---|---|---|---|---|---|
| Valiant Labs – RE | VALIANT-RE | 7.15 | 11.54 | 11.00 | -5.42% |
| GACM Tech | GATECH | 0.55 | 0.57 | 0.55 | -5.17% |
| Capital Trust | CAPTRUST | 60.72 | 63.54 | 61.01 | -4.55% |
| Chembond Mat Tech | CHEMBOND | 180.86 | 190.38 | 185.18 | -2.73% |
| Smarten Power | SMARTEN | 122.5 | 129.85 | 131.25 | -4.51% |
| Five-Star Fin. | FIVESTAR | 592.2 | 595.00 | 649.35 | -3.10% |
| MMEL | MMEL | 65.95 | 67.75 | 69.95 | -11.40% |
| Savy Infra | SAVY | 136.15 | 136.50 | 140.25 | -2.13% |
Several of these counters also posted low volumes, suggesting technical corrections rather than fundamental shifts in their valuations.
Broader Market Reflection
While benchmark indices remained largely flat amidst mixed cues, the surge in 52-week highs signals underlying momentum and strong buying interest in select small- and mid-cap counters. Conversely, the occurrence of 52-week lows, though fewer in number, highlights selective pain in certain segments, potentially due to post-earnings announcements or valuation fatigue. With the Q1FY26 earnings season in full swing, stock-specific volatility is highly likely to persist in the coming sessions, requiring traders to remain watchful of both breakout and breakdown patterns.
What’s Ahead For Investors?
The sharp contrast between 93 stocks hitting new 52-week highs and 51 sinking to fresh lows highlights a highly stock-specific market. Investors are rewarding mid- and small-cap companies with strong earnings, while pulling back from speculative or underperforming names. This reflects selective bullishness rather than a broad rally. With Q1FY26 results still rolling in, volatility is expected to persist. Global macro triggers like central bank policies and crude prices will also influence sentiment. Investors should stay selective, focus on earnings quality, and avoid chasing momentum blindly.
REF: https://www.nseindia.com/market-data/52-week-low-equity-market
Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations
